Molecular epidemiology of invasive Haemophilus influenzae disease in Portugal: an update of the post-vaccine period, 2011-2018.
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
23
01
2020
accepted:
10
03
2020
pubmed:
17
3
2020
medline:
17
3
2021
entrez:
16
3
2020
Statut:
ppublish
Résumé
Haemophilus influenzae reference laboratory from Portugal characterized the entire collection of 260 H. influenzae invasive isolates received between 2011 and 2018, with the purpose of updating the last published data (2002-2010). Capsular serotypes and antimicrobial susceptibility patterns were determined. The ftsI gene encoding the transpeptidase domain of PBP3 was sequenced for β-lactamase-negative ampicillin-resistant (BLNAR) isolates. Multilocus sequence typing (MLST) was performed to examine genetic relatedness among isolates. The majority of H. influenzae invasive isolates are nonencapsulated (NTHi-79.2%). Among encapsulated isolates (20.8%), the most characterized serotype was serotype b (13.5%), followed by serotype f (3.1%), serotype a (2.7%), and serotype e (1.5%). In contrast to NTHi that mainly affected the elderly (64.0%; ≥ 65 years old), most encapsulated isolates were characterized in preschool children (55.6%). Comparing the two periods, β-lactamase production increased from 10.4 to 13.5% (p = 0.032) and low-BLNAR (MIC ≥ 1 mg/L) isolates from 7.7 to 10.5% (p = 0.017). NTHi showed high genetic diversity (60.7%), in opposition to encapsulated isolates that were clonal within each serotype. Interestingly, ST103 and ST57 were the predominant STs among NTHi, with ST103 being associated with β-lactamase-producers and ST57 with non-β-lactamase-producers. In Portugal, susceptible and genetically diverse NTHi H. influenzae continues to be responsible for invasive disease, mainly in the elderly. Nevertheless, we are now concerned with Hib circulating in children we believe to have been vaccinated. Our data reiterates the need for continued surveillance, which will be useful in the development of public health prevention strategies.
Identifiants
pubmed: 32172370
doi: 10.1007/s10096-020-03865-0
pii: 10.1007/s10096-020-03865-0
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1471-1480Références
Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, Cherian T (2009) Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 374(9693):903–911
pubmed: 19748399
Ulanova M, Tsang RS (2009) Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect Genet Evol 9(4):594–605
pubmed: 19460326
Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, Daly JA, Pavia AT (2011) Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis 17(9):1645–1650
pubmed: 21888789
pmcid: 3322072
Pittman M (1931) Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med. 53(4):471–492
pubmed: 19869858
pmcid: 2131978
Peltola H (2000) Worldwide Haemophilus influenzae type b disease at the beginning of the 21
pubmed: 10756001
pmcid: 100154
van Alphen L, Bijlmer HA (1990) Molecular epidemiology of Haemophilus influenzae type b. Pediatrics 85(4):636–642
pubmed: 2179853
McIntyre PB, O'Brien KL, Greenwood B, van de Beek D (2012) Effect of vaccines on bacterial meningitis worldwide. Lancet 380(9854):1703–1711. https://doi.org/10.1016/S0140-6736(12)61187-8
doi: 10.1016/S0140-6736(12)61187-8
pubmed: 23141619
WHO-Immunization, Vaccines and Biologicals (2019) Haemophilus influenzae type b. https://www.who.int/immunization/diseases/hib/en/ . Accessed 18 November 2019
Campos J, Hernando M, Roman F, Perez-Vazquez M, Aracil B, Oteo J, Lazaro E, de Abajo F (2004) Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J Clin Microbiol 42(2):524–529
pubmed: 14766811
pmcid: 344522
Dworkin MS, Park L, Borchardt SM (2007) The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons ≥65 years old. Clin Infect Dis 44:810–816
pubmed: 17304452
Ladhani SN, Collins S, Vickers A, Litt DJ, Crawford C, Ramsay ME, Slack MP (2012) Invasive Haemophilus influenzae serotype e and f disease, England and Wales. Emerg Infect Dis 18(5):725–732
pubmed: 22515912
pmcid: 3358072
Puig C, Grau I, Marti S, Tubau F, Calatayud L, Pallares R, Liñares J, Ardanuy C (2014) Clinical and molecular epidemiology of Haemophilus influenzae causing invasive disease in adult patients. PLoS One 9(11):e11271. https://doi.org/10.1371/journal.pone.0112711
doi: 10.1371/journal.pone.0112711
Butler DF, Myers AL (2018) Changing epidemiology of Haemophilus influenzae in children. Infect Dis Clin North Am 32(1):119–128
pubmed: 29233576
Giufrè M, Fabiani M, Cardines R, Riccardo F, Caporali MG, D'Ancona F, Pezzotti P, Cerquetti M (2018) Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012–2016. Vaccine 36(45):6615–6622
pubmed: 30292458
Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME, European Union Invasive Bacterial Infection Surveillance Participants (2010) Invasive Haemophilus influenzae disease, Europe, 1996–2006. Emerg Infect Dis 16:455–463
pubmed: 20202421
pmcid: 3322004
ECDC- European Centre for Disease Prevention and Control (2019) Haemophilus influenzae. In: ECDC. Annual epidemiological report for 2017. ECDC, Stockholm
Whittaker R, Economopoulou A, Dias JG, Bancroft E, Ramliden M, Celentano LP, European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease (2017) Epidemiology of invasive Haemophilus influenzae disease, Europe, 2007–2014. Emerg Infect Dis 23(3):396–404
pubmed: 28220749
pmcid: 5382729
Bajanca P, Caniça M, Multicenter Study Group (2004) Emergence of nonencapsulated and encapsulated non-b-type invasive Haemophilus influenzae isolates in Portugal (1989–2001). J Clin Microbiol 42(2):807–810
pubmed: 14766857
pmcid: 344485
Bajanca-Lavado MP, Simões AS, Betencourt CR, Sá-Leão R, Portuguese Group for Study of Haemophilus influenzae invasive infection (2014) Characteristics of Haemophilus influenzae invasive isolates from Portugal following routine childhood vaccination against H. influenzae serotype b (2002–2010). Eur J Clin Microbiol Infect Dis 33:603–610
pubmed: 24154654
Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M (2001) Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45(6):1693–1699
pubmed: 11353613
pmcid: 90533
The European Committee on Antimicrobial Susceptibility Testing. (Version 9.0, 2019) Breakpoint tables for interpretation of MICs and zone diameters: 50–54. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf . Accessed 18 November 2019
Shuel ML, Tsang RSW (2009) Canadian β-lactamase-negative Haemophilus influenzae isolates showing decreased susceptibility toward ampicillin have significant penicillin binding protein 3 mutations. Diagn Microbiol and Infect Dis 63:379–383
Barbosa AR, Giufrè M, Cerquetti M, Bajanca-Lavado MP (2011) Polymorphism in ftsI gene and β-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of β-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. J Antimicrob Chemother 66(4):788–796
pubmed: 21393206
pmcid: 3058566
Lam TT, Claus H, Elias J, Frosch M, Vogel U (2015) Ampicillin resistance of invasive Haemophilus influenzae isolates in Germany 2009–2012. Int J Med Microbiol 305(7):748–755
pubmed: 26321008
Heinz E (2018) The return of Pfeiffer's bacillus: Rising incidence of ampicillin resistance in Haemophilus influenzae. Microb Genom 4(9). https://doi.org/10.1099/mgen.0.000214
Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, Kroll JS, Popovic T, Spratt BG (2003) Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol 41(4):1623–1636
pubmed: 12682154
pmcid: 153921
Erwin AL, Smith AL (2007) Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol 15:355–362
pubmed: 17600718
LaCross NC, Marrs CF, Gilsdorf JR (2013) Population structure in nontypeable Haemophilus influenzae. Infect Genet Evol 14:125–136
pubmed: 23266487
De Chiara M, Hood D, Muzzi A, Pickard DJ, Perkins T, Pizza M, Dougan G, Rappuoli R, Moxon ER, Soriani M, Donati C (2014) Genome sequencing of disease and carriage isolates of nontypeable Haemophilus influenzae identifies discrete population structure. Proc Natl Acad Sci USA 111:5439–5444
pubmed: 24706866
Pinto M, González-Díaz A, Machado MP, Duarte S, Vieira L, Carriço JA, Marti S, Bajanca-Lavado MP, Gomes JP (2019) Insights into the population structure and pan-genome of Haemophilus influenzae. Infect Genet Evol 67:126–135. https://doi.org/10.1016/j.meegid.2018.10.025
doi: 10.1016/j.meegid.2018.10.025
pubmed: 30391557
Falla TJ, Crook DW, Brophy LN, Maskell D, Kroll JS, Moxon ER (1994) PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 32(10):2382–2386
pubmed: 7814470
pmcid: 264070
Cerquetti M, Giufrè M, Cardines R, Mastrantonio P (2007) First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates. Antimicrob Agents Chemother 51:3155–3161
pubmed: 17620383
pmcid: 2043221
Kumar S, Stecher G, Tamura K (2016) Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol Biol Evol 33:1870–1874
pubmed: 27004904
pmcid: 27004904
Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carriço JA (2012) PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC bioinformatics 13(1):87–97
pubmed: 22568821
pmcid: 3403920
Tristram S, Jacobs MR, Appelbaum PC (2007) Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 20(2):368–389
pubmed: 17428889
pmcid: 1865592
García-Cobos S, Campos J, Lázaro E, Román F, Cercenado E, García-Rey C, Pérez-Vázquez M, Oteo J, de Abajo F (2007) Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 51:2564–2573
pubmed: 17470649
pmcid: 1913223
Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, Pasquier C (2002) Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 46(7):2208–2218
pubmed: 12069976
pmcid: 127296
Agrawal A, Murphy TF (2011) Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol 49(11):3728–3732
pubmed: 21900515
pmcid: 3209133
Van Eldere J, Slack MP, Ladhani S, Cripps AW (2014) Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis 14(12):1281–1292
pubmed: 25012226
Soeters HM, Blain A, Pondo T, Doman B, Farley MM, Harrison LH, Lynfield R, Miller L, Petit S, Reingold A, Schaffner W, Thomas A, Zansky SM, Wang X, Briere EC (2018) Current epidemiology and trends in invasive Haemophilus influenzae disease-United States, 2009–2015. Clin Infect Dis 67(6):881–889
pubmed: 29509834
pmcid: 6181225
Garmendia J, Viadas C, Calatayud L, Mell JC, Martí-Lliteras P, Euba B, Llobet E, Gil C, Bengoechea JA, Redfield RJ, Liñares J (2014) Characterization of nontypable Haemophilus influenzae isolates recovered from adult patients with underlying chronic lung disease reveals genotypic and phenotypic traits associated with persistent infection. PLoS ONE 9:e97020. https://doi.org/10.1371/journal.pone.0097020
doi: 10.1371/journal.pone.0097020
pubmed: 24824990
pmcid: 4019658
Charania NA, Moghadas SM (2017) Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b. BMC Public Health 17(1):705. https://doi.org/10.1186/s12889-017-4714-9
doi: 10.1186/s12889-017-4714-9
pubmed: 28903749
pmcid: 5598080
Garcia S, Lagos R, Muñoz A, Picón T, Rosa R, Alfonso A, Abriata G, Gentile A, Romanin V, Regueira M, Chiavetta L, Agudelo CI, Castañeda E, De la Hoz F, Higuera AB, Arce P, Cohen AL, Verani J, Zuber P, Gabastou JM, Pastor D, Flannery B, Andrus J (2012) Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries. Vaccine 30(2):486–492
pubmed: 22085550
Wang S, Tafalla M, Hanssens L, Dolhain J (2017) A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines. Expert Rev Vaccines 16(11):1095–1105
pubmed: 28971707
Giufrè M, Cardines R, Accogli M, Pardini M, Cerquetti M (2013) Identification of Haemophilus influenzae clones associated with invasive disease a decade after introduction of H. influenzae serotype b vaccination in Italy. Clin Vaccine Immunol 20(8):1223–1229
pubmed: 23761663
pmcid: 3754497
Tsang RS, Ulanova M (2017) The changing epidemiology of invasive Haemophilus influenzae disease: emergence and global presence of serotype a strains that may require a new vaccine for control. Vaccine 35(33):4270–4275
pubmed: 28666758
Bruce MG, DeByle TZ, Singleton Z, Hurlburt R, Bruden D, Wenger JD (2013) Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983–2011. Emerg Infect Dis 19(6):932–937
pubmed: 23735653
pmcid: 3713835
Resman F, Ristovski M, Ah J, Forsgren A, Gilsdorf JR, Jasir A, Kaijser B, Kronvall G, Riesbeck K (2012) Invasive disease caused by Haemophilus influenzae in Sweden 1997–2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect 17(11):1638–1645
Giufrè M, Cardines R, Brigante G, Orecchioni F, Cerquetti M (2017) Emergence of invasive Haemophilus influenzae type a disease in Italy. Clin Infect Dis 64(11):1626–1628
pubmed: 28369218
Garcia-Cobos S, Campos J, Roman F, Carrera C, Perez-Vazquez M, Aracil B, Oteo J (2008) Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method. Antimicrob Agents Chemother 52(7):2407–2414
pubmed: 18443129
pmcid: 2443874
Tsang RSW, Shuel M, Whyte K, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson J, Lefebvre B, Haldane D, Gad RR, German GJ, Needle R (2017) Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014. J Antimicrob Chemother 72(5):1314–1319
pubmed: 28137937
pmcid: 5890693
Clinical and Laboratory Standards Institute (CLSI) (2011) Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement. CLSI document M100-S21. CLSI, Wayne, PA, USA
Erwin AL, Sandstedt SA, Bonthuis PJ, Geelhood JL, Nelson KL, Unrath WC, Diggle MA, Theodore MJ, Pleatman CR, Mothershed EA, Sacchi CT, Mayer LW, Gilsdorf JR, Smith AL (2008) Analysis of genetic relatedness of Haemophilus influenzae isolates by multilocus sequence typing. J Bacteriol 190(4):1473–1483
pubmed: 18065541